Compare StocksIVZ vs PFE

Invesco Ltd. (IVZ) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, IVZ is undervalued at $28, with a DCF intrinsic value of $104 and a margin of safety of 73%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, IVZ has the wider margin of safety.

IVZ
Invesco Ltd.
$28.14
VS
PFE
Pfizer Inc.
$25.21

Rewards

IVZ
  • Free cash flow has grown at a 41.3% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • FCF yield of 11.6% is historically attractive — the business generates significant cash relative to its price.
  • PEG ratio of 0.38 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

IVZ
  • ROIC has declined by 6.5 percentage points over the past 4 years, which may signal competitive erosion.
  • Altman Z-Score of 1.39 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
IVZ
PFE
Valuation
$1.44B
Free Cash Flow
$12.38B
11.55%
FCF Yield
8.61%
N/A
Trailing P/E
19.24
9.42
Forward P/E
8.91
Quality & Moat
6.53%
ROIC
10.19%
-1.54%
ROE
8.31%
28.92%
Gross Margin
74.80%
0.38
PEG Ratio
13.77
Balance Sheet Safety
0.09
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
0.87
Net Debt / EBITDA
2.03
2.94%
Dividend Yield
6.61%
IVZ: 4Ties: 1PFE: 6
IVZPFE

Historical Fundamentals

Learn more →
IVZ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
IVZ
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-1.39B
Δ Market Cap
+$3.48B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
IVZ
73.0% Margin of Safety
Price is 73.0% below estimated fair value
Current Price: $28.14
Fair Value: $104.32
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
IVZ

What growth rate is the market pricing in at $28?

-2.6%
Market-Implied FCF Growth Rate

Market below historical growth — potential opportunity.

PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
IVZ
36/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
IVZ

Insufficient data for Beneish M-Score calculation (requires 2+ years).

PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
IVZ
Insiders 0.6%Institutions 97.3%Retail & Other 2.1%
No. of Institutional Holders871
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
IVZ
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
IVZ
0
Sells (3M)
2
Sells (12M)
Total value (12M): $6.05M
SHARP DOUGLAS J
Officer
$3.77M
@ $23.56 · 2025-10-31
BUTCHER STEPHANIE
Officer
$2.28M
@ $22.12 · 2025-09-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
IVZ
FearGreed
😐Neutral(58/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
IVZ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (58)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View IVZ Full AnalysisView PFE Full Analysis

Frequently Asked Questions: IVZ vs PFE

Is Invesco Ltd. or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, IVZ trades at a 73.0% margin of safety (intrinsic value $104 vs. price $28), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

Which stock has a wider economic moat, Invesco Ltd. or Pfizer Inc.?

IVZ scores 36/100 (None moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Invesco Ltd. in financial distress?

IVZ's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 2.1 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Invesco Ltd. or Pfizer Inc.?

Invesco Ltd. (IVZ) generates a 11.6% free cash flow yield, compared to Pfizer Inc.'s 8.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Invesco Ltd. or Pfizer Inc.?

PFE earns 10.2% ROIC versus IVZ's 6.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Invesco Ltd.'s or Pfizer Inc.'s?

IVZ's dividend earns a safety score of 65/100 (Safe), compared to PFE's 24/100 (Unsafe). IVZ has raised its dividend for 0 consecutive years.